BOTTNEURO
Bottneuro offers a unique, non-invasive therapy for early- and moderate-stage Alzheimer's Disease patients using electrical stimulations of neurons and glia cells in the brain. Bottoneuro develops stimulation protocols using the NENI technology platform.
BOTTNEURO
Industry:
Health Care Therapeutics
Founded:
2021-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.bottneuro.ch
Total Employee:
11+
Status:
Active
Contact:
+41 61 633 29 50
Total Funding:
150 K CHF
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Board_member
Board_member
Board_member
Current Employees Featured
Alois Hopf Co-Founder and CSO @ Bottneuro
Co-Founder and CSO
Bekim Osmani CEO and Co-Founder @ Bottneuro
CEO and Co-Founder
Founder
Investors List
Venture Kick
Venture Kick investment in Grant - Bottneuro
Official Site Inspections
http://www.bottneuro.ch
- Host name: server51.hostfactory.ch
- IP address: 185.117.169.194
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "Bottneuro"
Bottneuro | Precision medicine for brain health
Bottneuro is a startup from the University of Basel in Switzerland, specializing in fully personalized neurostimulation therapies based on each patient's MRI and PET data. ... mail@bottneuro.ch …See details»
Bottneuro AG | Precision Medicine for Brain Health
Bottneuro AG | Our vision is to become leading provider of diagnosis and treatment of AD using digital biomarkers, brain imaging and neuromodulation technologies ... mail@bottneuro.ch +41 …See details»
Bottneuro - Crunchbase Company Profile & Funding
Contact Email mail@bottneuro.ch Phone Number +41 61 633 29 50 Bottneuro offers a unique, non-invasive therapy for early- and moderate-stage Alzheimer's Disease patients using …See details»
Bottneuro AG - StiftungSchweiz
Bottneuro ist ein Startup der Universität Basel mit Sitz auf dem Novartis Campus. Wir entwickeln eine komplett personalisierte Neurostimulationstherapie für Alzheimerpatient:innen. Die …See details»
Latest news | Bottneuro | Digital solutions for …
Bottneuro AG is a spin-off of the University of Basel working on digital diagnostic solutions and non-invasive treatments for Alzheimer’s Disease (AD). Discover more ... mail@bottneuro.ch +41 61 515 00 43; Follow us: Headquarters. …See details»
Bottneuro AG - top100startup.ch
15.12.2022 Bottneuro secures CHF 4 million to develop its non-invasive Alzheimer's treatment (venturekick.ch) 15.12.2022 CHF 4 million for Bottneuro (startupticker.ch) 12.12.2022 IMD …See details»
Bottneuro AG - Venture Kick
Bottneuro AG: Bottneuro, a startup from the University of Basel on the Novartis campus, provides a fully personalized neurostimulation therapy based on each patient's MRI data. ...See details»
Bottneuro AG - Switzerland Innovation Park Basel Area
Bottneuro.ch. View all residents. Contact. Switzerland Innovation Park Basel Area AG Hegenheimermattweg 167A 4123 Allschwil, Switzerland +41 61 577 23 16 …See details»
Bottneuro 2025 Company Profile: Valuation, Funding & Investors
Bottneuro General Information Description. Developer of a brain therapy system designed to treat people with chronic neuropathic pain. The company's system is made from plant-based …See details»
Bottneuro secures CHF 4 million to develop its non …
Dec 15, 2022 The startup, which is developing a non-invasive, home-based treatment for early- and moderate-stage Alzheimer's patients, closed the first tranche of the bridge round, bringing its total capital raised in 2022 to CHF 4 …See details»
Bottneuro wins CHF 150,000 to advance diagnosis and digital …
Dec 17, 2021 Bottneuro will facilitate the early-stage diagnosis of Alzheimer’s disease (AD) and aims to become a leading provider of personalized digital therapies for AD. The Basel-based …See details»
Bottneuro launches Priority Access Program after successful study
Aug 8, 2024 Founded in 2021, Bottneuro is developing a non-invasive neuromodulation therapy that utilizes patient-specific MRI data to deliver precise electrical stimulation to affected brain …See details»
Bottneuro AG - startup.ch
Bottneuro, a startup from the University of Basel on the Novartis campus, provides a fully personalized neurostimulation therapy based on each patient's MRI data. Our device is …See details»
CHF 150,000 to advance personalized therapies for Alzheimer’s …
Dec 20, 2021 Bottneuro will fabricate the first series of 100 devices and start clinical trials in 2022; the first PET scan centers will be established in 2023. To support these plans, a CHF 10 …See details»
Bottneuro wins CHF 150,000 to advance diagnosis and digital …
Dec 17, 2021 To support these plans, a CHF 10 million Series A is planned for 2022 and 2023. The Venture Kick funds, complemented by a Kick Fund investment, will lay the foundation for …See details»
Bottneuro Company Information - Funding, Investors, and More
Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»
Bottneuro AG: 3D-printed, patient-specific therapy for Alzheimer’s ...
Bottneuro is developing a non-invasive, home-based therapy system for AD patients, using personalized transcranial electrical stimulation of selected brain areas. Our innovative method …See details»
CHF 4 million for Bottneuro - startupticker.ch
Dec 15, 2022 CH-6003 Luzern; Tel: +41 41 226 20 80; Fax: +41 41 226 20 89; news@startupticker.ch; Submit an event; Submit special offer; Login Register. Cancel Forgot …See details»
Bottneuro advancing personalized Alzheimer’s therapy
Feb 11, 2021 Bottneuro is planning to use a positron emission tomography (PET) device developed by Positrigo to accurately localize the correct areas of the brain to treat in …See details»
Bottneuros Hirnstimulator bereit für den Einsatz an Patienten
Nov 24, 2023 Anschliessend erstellt Bottneuro eine computergestützte Simulation, um die induzierten elektrischen Felder visuell darzustellen und eine endgültige Festlegung der …See details»